We are live on
!
Find out more
GCM
Glenview Capital Management Portfolio holdings
AUM
$3.98B
1-Year Est. Return
20.52%
This Fund
S&P 500
This Quarter
Est. Return
-13.27%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$4B
AUM Growth
-$942M
(-19%)
Cap. Flow
-$186M
Cap. Flow
% of AUM
-4.65%
Top 10 Holdings %
Top 10 Hldgs %
60.38%
Holding
66
New
6
Increased
24
Reduced
16
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$124M |
| 2 |
Microsoft
MSFT
|
+$55.7M |
| 3 |
FMC
FMC
|
+$49.1M |
| 4 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
+$40.7M |
| 5 |
Aptiv
APTV
|
+$39.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$212M |
| 2 |
MTOR
MERITOR, Inc.
MTOR
|
+$126M |
| 3 |
Cencora
COR
|
+$116M |
| 4 |
Universal Health Services
UHS
|
+$89.7M |
| 5 |
McKesson
MCK
|
+$67.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.56% |
| 2 | Technology | 19.65% |
| 3 | Industrials | 9.92% |
| 4 | Materials | 8.09% |
| 5 | Consumer Staples | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OHPAU
51
DELISTED
Orion Acquisition Corp. Unit
OHPAU
| $4.76M | 0.12% |
485,001
| – | – |
|
52
Rapid Micro Biosystems
RPID
$105M
| $3.23M | 0.08% |
750,000
+84,193
| +13% | +$392K |
|
53
Ouster
OUST
$3.04B
| $1.83M | 0.05% |
112,898
| – | – |
|
54
Hyperfine
HYPR
$97.3M
| $1.35M | 0.03% |
605,052
-371,948
| -38% | -$1.1M |
|
55
Flex
FLEX
$45B
| $191K | ﹤0.01% |
17,516
-3,258,043
| -99% | -$40.4M |
|
56
Alibaba
BABA
$308B
| – | – |
-78,789
| Closed | -$8.57M |
|
|
57
Bausch Health
BHC
$2.35B
| – | – |
-9,256,661
| Closed | -$212M |
|
|
58
Cencora
COR
$61.7B
| – | – |
-752,648
| Closed | -$116M |
|
59
DaVita
DVA
$12.1B
| – | – |
-129,100
| Closed | -$14.6M |
|
60
Evolus
EOLS
$407M
| – | – |
-394,810
| Closed | -$4.43M |
|
61
Insperity
NSP
$1.95B
| – | – |
-381,875
| Closed | -$38.3M |
|
|
62
Universal Health Services
UHS
$10.4B
| – | – |
-618,871
| Closed | -$89.7M |
|
63
Union Pacific
UNP
$176B
| – | – |
-46,185
| Closed | -$12.6M |
|
|
ENDP
64
DELISTED
Endo International plc
ENDP
| – | – |
-1,126,435
| Closed | -$2.6M |
|
|
MTOR
65
DELISTED
MERITOR, Inc.
MTOR
| – | – |
-3,544,333
| Closed | -$126M |
|
|
BHVN
66
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| – | – |
-158,301
| Closed | -$18.8M |
|
Similar funds
MAM
USCWA
AI
LWCA
JSW
AS
BWA
BCP
Glenview Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Glenview Capital Management held 66 positions worth $4B, down 19% from $4.94B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Glenview Capital Management withdrew a net $186M in Q2 2022, closing 11 positions and reducing 16 holdings. Its most notable exit was Bausch Health, an estimated $212M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 49% a quarter earlier, followed by Technology and Industrials.
Against the trend, Glenview Capital Management opened a new position in Microsoft worth $52.8M.
- Glenview Capital Management's largest Q2 2022 buy was Microsoft: 205,392 shares worth $52.8M.
- Glenview Capital Management added most to Cigna in Q2 2022, an estimated $124M increase.
- Glenview Capital Management's biggest Q2 2022 reduction was McKesson, cutting an estimated $67.3M.
- Glenview Capital Management fully exited Bausch Health in Q2 2022, selling an estimated $212M.
- Glenview Capital Management's ten largest holdings make up 60% of its $4B portfolio in Q2 2022.
- Glenview Capital Management opened 6 new positions and closed 11 in Q2 2022.
- Glenview Capital Management's portfolio value fell 19% quarter-over-quarter to $4B.
Based on Glenview Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.